Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 144 Insider Sale of Securities
  2. 4 Planned sale See Remarks sold 25,000 shares at an average $81.85 ($2,046,351)
  3. 4 Planned sale President, Oncology sold 8,333 shares at an average $80.89 ($674,069)
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 4 Planned sale Director sold 10,000 shares at an average $114.81 ($1,148,083)
  8. 4 Planned sale President, Oncology sold 8,333 shares at an average $116.10 ($967,448)
  9. 4 Planned sale See Remarks sold 10,000 shares at an average $116.07 ($1,160,731)
  10. 4 Planned sale See Remarks sold 25,000 shares at an average $116.26 ($2,906,601)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 144 Insider Sale of Securities
  14. 4 Gift Chief Business Officer gave 17,100 shares (gift)
  15. 8-K Event Executive or director change · Regulation FD disclosure
  16. 4 Planned sale President, Oncology sold 296 shares at $100.82 ($29,843)
  17. 4 Option exercise Chief Business Officer acquired 17,493 shares (option exercise)
  18. 4 Planned sale See Remarks sold 10,000 shares at an average $113.49 ($1,134,947)
  19. 4 Planned sale Director sold 10,000 shares at an average $110.69 ($1,106,940)
  20. 144 Insider Sale of Securities

Page 1 of 103 · 2,050 filings